COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Fundamental Analysis & Valuation

AMS:CCEP • GB00BDCPN049

Current stock price

82.9 EUR
-2.4 (-2.81%)
Last:

This CCEP.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CCEP.AS Profitability Analysis

1.1 Basic Checks

  • In the past year CCEP was profitable.
  • In the past year CCEP had a positive cash flow from operations.
  • CCEP had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CCEP had a positive operating cash flow.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • CCEP has a Return On Assets of 6.50%. This is amongst the best in the industry. CCEP outperforms 83.33% of its industry peers.
  • CCEP has a better Return On Equity (24.79%) than 86.67% of its industry peers.
  • CCEP has a Return On Invested Capital of 9.38%. This is in the better half of the industry: CCEP outperforms 76.67% of its industry peers.
Industry RankSector Rank
ROA 6.5%
ROE 24.79%
ROIC 9.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of CCEP (9.29%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CCEP has grown nicely.
  • Looking at the Operating Margin, with a value of 13.19%, CCEP is doing worse than 60.00% of the companies in the same industry.
  • CCEP's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CCEP (35.57%) is worse than 83.33% of its industry peers.
  • CCEP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.19%
PM (TTM) 9.29%
GM 35.57%
OM growth 3Y0.73%
OM growth 5Y8.95%
PM growth 3Y2.19%
PM growth 5Y14.63%
GM growth 3Y-0.63%
GM growth 5Y-0.27%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. CCEP.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCEP is creating some value.
  • There is no outstanding debt for CCEP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • CCEP has an Altman-Z score of 2.34. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.34, CCEP is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
  • CCEP has a debt to FCF ratio of 5.34. This is a neutral value as CCEP would need 5.34 years to pay back of all of its debts.
  • CCEP has a better Debt to FCF ratio (5.34) than 90.00% of its industry peers.
  • A Debt/Equity ratio of 1.30 is on the high side and indicates that CCEP has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.30, CCEP is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF 5.34
Altman-Z 2.34
ROIC/WACC1.1
WACC8.51%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • CCEP has a Current Ratio of 0.80. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CCEP (0.80) is worse than 83.33% of its industry peers.
  • A Quick Ratio of 0.60 indicates that CCEP may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.60, CCEP is doing worse than 63.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.6
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. CCEP.AS Growth Analysis

3.1 Past

  • CCEP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.43%, which is quite impressive.
  • CCEP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 31.33% yearly.
  • Looking at the last year, CCEP shows a small growth in Revenue. The Revenue has grown by 2.27% in the last year.
  • CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.53% yearly.
EPS 1Y (TTM)38.43%
EPS 3Y8.96%
EPS 5Y31.33%
EPS Q2Q%68.87%
Revenue 1Y (TTM)2.27%
Revenue growth 3Y6.46%
Revenue growth 5Y14.53%
Sales Q2Q%0.16%

3.2 Future

  • Based on estimates for the next years, CCEP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.98% on average per year.
  • The Revenue is expected to grow by 4.08% on average over the next years.
EPS Next Y8.59%
EPS Next 2Y8.99%
EPS Next 3Y8.93%
EPS Next 5Y9.98%
Revenue Next Year2.63%
Revenue Next 2Y3.24%
Revenue Next 3Y3.49%
Revenue Next 5Y4.08%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

2

4. CCEP.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.46, the valuation of CCEP can be described as rather expensive.
  • CCEP's Price/Earnings ratio is in line with the industry average.
  • CCEP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.73.
  • The Price/Forward Earnings ratio is 18.27, which indicates a rather expensive current valuation of CCEP.
  • 60.00% of the companies in the same industry are cheaper than CCEP, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.72. CCEP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.46
Fwd PE 18.27
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CCEP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CCEP is more expensive than 60.00% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CCEP.
Industry RankSector Rank
P/FCF 18.59
EV/EBITDA 13.04
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCEP does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of CCEP may justify a higher PE ratio.
PEG (NY)2.26
PEG (5Y)0.62
EPS Next 2Y8.99%
EPS Next 3Y8.93%

4

5. CCEP.AS Dividend Analysis

5.1 Amount

  • CCEP has a Yearly Dividend Yield of 2.30%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.74, CCEP is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.91, CCEP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

  • On average, the dividend of CCEP grows each year by 8.87%, which is quite nice.
Dividend Growth(5Y)8.87%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 47.73% of the earnings are spent on dividend by CCEP. This is a bit on the high side, but may be sustainable.
  • CCEP's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP47.73%
EPS Next 2Y8.99%
EPS Next 3Y8.93%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

CCEP.AS Fundamentals: All Metrics, Ratios and Statistics

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (3/19/2026, 7:00:00 PM)

82.9

-2.4 (-2.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-17
Earnings (Next)04-28
Inst Owners37.81%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap37.23B
Revenue(TTM)20.90B
Net Income(TTM)1.94B
Analysts75.45
Price Target93.05 (12.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Yearly Dividend1.74
Dividend Growth(5Y)8.87%
DP47.73%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.63%
PT rev (3m)6.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.53%
EPS NY rev (3m)-0.19%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 19.46
Fwd PE 18.27
P/S 1.78
P/FCF 18.59
P/OCF 12.61
P/B 4.75
P/tB N/A
EV/EBITDA 13.04
EPS(TTM)4.26
EY5.14%
EPS(NY)4.54
Fwd EY5.47%
FCF(TTM)4.46
FCFY5.38%
OCF(TTM)6.58
OCFY7.93%
SpS46.54
BVpS17.45
TBVpS-20.47
PEG (NY)2.26
PEG (5Y)0.62
Graham Number40.89
Profitability
Industry RankSector Rank
ROA 6.5%
ROE 24.79%
ROCE 12.37%
ROIC 9.38%
ROICexc 9.8%
ROICexgc 48.56%
OM 13.19%
PM (TTM) 9.29%
GM 35.57%
FCFM 9.58%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.73%
OM growth 5Y8.95%
PM growth 3Y2.19%
PM growth 5Y14.63%
GM growth 3Y-0.63%
GM growth 5Y-0.27%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF 5.34
Debt/EBITDA 2.78
Cap/Depr 102.93%
Cap/Sales 4.55%
Interest Coverage 11.68
Cash Conversion 80.24%
Profit Quality 103.14%
Current Ratio 0.8
Quick Ratio 0.6
Altman-Z 2.34
F-Score7
WACC8.51%
ROIC/WACC1.1
Cap/Depr(3y)102.03%
Cap/Depr(5y)87.4%
Cap/Sales(3y)4.53%
Cap/Sales(5y)4.06%
Profit Quality(3y)124.09%
Profit Quality(5y)139.37%
High Growth Momentum
Growth
EPS 1Y (TTM)38.43%
EPS 3Y8.96%
EPS 5Y31.33%
EPS Q2Q%68.87%
EPS Next Y8.59%
EPS Next 2Y8.99%
EPS Next 3Y8.93%
EPS Next 5Y9.98%
Revenue 1Y (TTM)2.27%
Revenue growth 3Y6.46%
Revenue growth 5Y14.53%
Sales Q2Q%0.16%
Revenue Next Year2.63%
Revenue Next 2Y3.24%
Revenue Next 3Y3.49%
Revenue Next 5Y4.08%
EBIT growth 1Y28.23%
EBIT growth 3Y7.25%
EBIT growth 5Y24.78%
EBIT Next Year44.52%
EBIT Next 3Y17.83%
EBIT Next 5Y13.13%
FCF growth 1Y-5.61%
FCF growth 3Y-4.9%
FCF growth 5Y13.11%
OCF growth 1Y-3.53%
OCF growth 3Y0.24%
OCF growth 5Y14.66%

COCA-COLA EUROPACIFIC PARTNE / CCEP.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for COCA-COLA EUROPACIFIC PARTNE?

ChartMill assigns a fundamental rating of 4 / 10 to CCEP.AS.


What is the valuation status of COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) stock?

ChartMill assigns a valuation rating of 2 / 10 to COCA-COLA EUROPACIFIC PARTNE (CCEP.AS). This can be considered as Overvalued.


How profitable is COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) stock?

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) has a profitability rating of 6 / 10.


What is the valuation of COCA-COLA EUROPACIFIC PARTNE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) is 19.46 and the Price/Book (PB) ratio is 4.75.


Can you provide the expected EPS growth for CCEP stock?

The Earnings per Share (EPS) of COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) is expected to grow by 8.59% in the next year.